Logo image of DOC.CA

CLOUDMD SOFTWARE & SERVICES (DOC.CA) Stock Fundamental Analysis

TSX-V:DOC - TSX Venture Exchange - CA18912C1023 - Common Stock - Currency: CAD

0.035  0 (0%)

Fundamental Rating

2

Taking everything into account, DOC scores 2 out of 10 in our fundamental rating. DOC was compared to 15 industry peers in the Health Care Providers & Services industry. DOC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DOC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DOC had negative earnings in the past year.
In the past year DOC has reported a negative cash flow from operations.
DOC had negative earnings in each of the past 5 years.
DOC had a negative operating cash flow in each of the past 5 years.
DOC.CA Yearly Net Income VS EBIT VS OCF VS FCFDOC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

The Return On Assets of DOC (-100.54%) is worse than 84.21% of its industry peers.
Looking at the Return On Equity, with a value of -281.88%, DOC is doing worse than 78.95% of the companies in the same industry.
Industry RankSector Rank
ROA -100.54%
ROE -281.88%
ROIC N/A
ROA(3y)-64.48%
ROA(5y)-46.08%
ROE(3y)-133.64%
ROE(5y)-91.05%
ROIC(3y)N/A
ROIC(5y)N/A
DOC.CA Yearly ROA, ROE, ROICDOC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400

1.3 Margins

DOC has a Gross Margin (38.65%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of DOC has grown nicely.
The Profit Margin and Operating Margin are not available for DOC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y8.12%
DOC.CA Yearly Profit, Operating, Gross MarginsDOC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

More info and screens

1

2. Health

2.1 Basic Checks

DOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DOC has been increased compared to 1 year ago.
DOC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOC is higher compared to a year ago.
DOC.CA Yearly Shares OutstandingDOC.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
DOC.CA Yearly Total Debt VS Total AssetsDOC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -4.51, we must say that DOC is in the distress zone and has some risk of bankruptcy.
DOC has a Altman-Z score of -4.51. This is in the lower half of the industry: DOC underperforms 78.95% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that DOC is not too dependend on debt financing.
DOC has a Debt to Equity ratio of 0.24. This is amongst the best in the industry. DOC outperforms 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -4.51
ROIC/WACCN/A
WACC5.7%
DOC.CA Yearly LT Debt VS Equity VS FCFDOC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

DOC has a Current Ratio of 0.77. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC has a Current ratio of 0.77. This is in the lower half of the industry: DOC underperforms 73.68% of its industry peers.
DOC has a Quick Ratio of 0.77. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC has a Quick ratio of 0.77. This is in the lower half of the industry: DOC underperforms 73.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.77
DOC.CA Yearly Current Assets VS Current LiabilitesDOC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

DOC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.23%, which is quite impressive.
Looking at the last year, DOC shows a very negative growth in Revenue. The Revenue has decreased by -22.09% in the last year.
Measured over the past years, DOC shows a very strong growth in Revenue. The Revenue has been growing by 137.56% on average per year.
EPS 1Y (TTM)52.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.06%
Revenue 1Y (TTM)-22.09%
Revenue growth 3Y82.25%
Revenue growth 5Y137.56%
Sales Q2Q%-12.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 22.65% on average over the next years. This is a very strong growth
EPS Next Y42.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.8%
Revenue Next 2Y22.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DOC.CA Yearly Revenue VS EstimatesDOC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
DOC.CA Yearly EPS VS EstimatesDOC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DOC. In the last year negative earnings were reported.
Also next year DOC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DOC.CA Price Earnings VS Forward Price EarningsDOC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DOC.CA Per share dataDOC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DOC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLOUDMD SOFTWARE & SERVICES

TSX-V:DOC (7/10/2024, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-27 2024-05-27
Earnings (Next)08-26 2024-08-26
Inst Owners0.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.66M
Analysts84.44
Price Target0.51 (1357.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.82%
Min Revenue beat(2)-24.69%
Max Revenue beat(2)-16.95%
Revenue beat(4)0
Avg Revenue beat(4)-15.49%
Min Revenue beat(4)-24.69%
Max Revenue beat(4)-4.62%
Revenue beat(8)0
Avg Revenue beat(8)-14.53%
Revenue beat(12)3
Avg Revenue beat(12)-9.31%
Revenue beat(16)4
Avg Revenue beat(16)-7.9%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.3
BVpS0.09
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -100.54%
ROE -281.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.65%
FCFM N/A
ROA(3y)-64.48%
ROA(5y)-46.08%
ROE(3y)-133.64%
ROE(5y)-91.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y8.12%
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.55%
Cap/Sales 2.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.77
Altman-Z -4.51
F-Score4
WACC5.7%
ROIC/WACCN/A
Cap/Depr(3y)24.73%
Cap/Depr(5y)19.01%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.06%
EPS Next Y42.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.09%
Revenue growth 3Y82.25%
Revenue growth 5Y137.56%
Sales Q2Q%-12.75%
Revenue Next Year13.8%
Revenue Next 2Y22.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year122.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.48%
OCF growth 3YN/A
OCF growth 5YN/A